Significant MP calls for MARC Strains (IMPC_001)  

 

Total number of results: 1169

Gene / Allele Procedure Parameter Zygosity Sex Phenotype P-value Graph
Cyp17a1
Cyp17a1tm1b(EUCOMM)Wtsi
Gross Pathology and Tissue Collection Kidney homozygote Male small kidney 0.0
Kdm1a
Kdm1atm1(NCOM)Mfgc
Gross Pathology and Tissue Collection Kidney heterozygote Female small kidney 0.0
Nxn
Nxntm1b(EUCOMM)Wtsi
Viability Primary Screen Outcome homozygote Female preweaning lethality, complete penetrance 0.0
Nxn
Nxntm1b(EUCOMM)Wtsi
Viability Primary Screen Outcome homozygote Male preweaning lethality, complete penetrance 0.0
Psmd14
Psmd14tm1b(NCOM)Cmhd
Viability Primary Screen Outcome homozygote Female preweaning lethality, complete penetrance 0.0
Psmd14
Psmd14tm1b(NCOM)Cmhd
Viability Primary Screen Outcome homozygote Male preweaning lethality, complete penetrance 0.0
Mir429
Mir429tm1(mirKO)Wtsi
Viability Primary Screen Outcome homozygote Female preweaning lethality, complete penetrance 0.0
Mir429
Mir429tm1(mirKO)Wtsi
Viability Primary Screen Outcome homozygote Male preweaning lethality, complete penetrance 0.0
Fntb
Fntbtm1b(EUCOMM)Hmgu
Viability Primary Screen Outcome homozygote Female preweaning lethality, complete penetrance 0.0
Fntb
Fntbtm1b(EUCOMM)Hmgu
Viability Primary Screen Outcome homozygote Male preweaning lethality, complete penetrance 0.0
Usp10
Usp10tm1(NCOM)Mfgc
Viability Primary Screen Outcome homozygote Female preweaning lethality, complete penetrance 0.0
Usp10
Usp10tm1(NCOM)Mfgc
Viability Primary Screen Outcome homozygote Male preweaning lethality, complete penetrance 0.0
Ppp1cb
Ppp1cbem2(IMPC)Marc
Viability Primary Screen Outcome homozygote Female preweaning lethality, complete penetrance 0.0
Ppp1cb
Ppp1cbem2(IMPC)Marc
Viability Primary Screen Outcome homozygote Male preweaning lethality, complete penetrance 0.0
Mir320
Mir320tm1(mirKO)Wtsi
Viability Primary Screen Outcome homozygote Female preweaning lethality, complete penetrance 0.0
Mir320
Mir320tm1(mirKO)Wtsi
Viability Primary Screen Outcome homozygote Male preweaning lethality, complete penetrance 0.0
Kmt2c
Kmt2cem2(IMPC)Marc
Viability Primary Screen Outcome homozygote Female preweaning lethality, complete penetrance 0.0
Kmt2c
Kmt2cem2(IMPC)Marc
Viability Primary Screen Outcome homozygote Male preweaning lethality, complete penetrance 0.0
Emc4
Emc4tm1(KOMP)Wtsi
Viability Primary Screen Outcome homozygote Female preweaning lethality, complete penetrance 0.0
Emc4
Emc4tm1(KOMP)Wtsi
Viability Primary Screen Outcome homozygote Male preweaning lethality, complete penetrance 0.0
Alg1
Alg1tm1b(KOMP)Wtsi
Viability Primary Screen Outcome homozygote Female preweaning lethality, complete penetrance 0.0
Alg1
Alg1tm1b(KOMP)Wtsi
Viability Primary Screen Outcome homozygote Male preweaning lethality, complete penetrance 0.0
Oxsm
Oxsmem2(IMPC)Marc
Viability Primary Screen Outcome homozygote Female preweaning lethality, complete penetrance 0.0
Oxsm
Oxsmem2(IMPC)Marc
Viability Primary Screen Outcome homozygote Male preweaning lethality, complete penetrance 0.0
Prpf31
Prpf31tm1a(EUCOMM)Wtsi
Viability Primary Screen Outcome homozygote Female preweaning lethality, complete penetrance 0.0
Prpf31
Prpf31tm1a(EUCOMM)Wtsi
Viability Primary Screen Outcome homozygote Male preweaning lethality, complete penetrance 0.0
Uchl5
Uchl5tm1(NCOM)Mfgc
Viability Primary Screen Outcome homozygote Female preweaning lethality, complete penetrance 0.0
Uchl5
Uchl5tm1(NCOM)Mfgc
Viability Primary Screen Outcome homozygote Male preweaning lethality, complete penetrance 0.0
Hnrnpm
Hnrnpmem1(IMPC)Marc
Viability Primary Screen Outcome homozygote Female preweaning lethality, complete penetrance 0.0
Hnrnpm
Hnrnpmem1(IMPC)Marc
Viability Primary Screen Outcome homozygote Male preweaning lethality, complete penetrance 0.0
Snx25
Snx25tm1b(KOMP)Wtsi
Viability Primary Screen Outcome homozygote Female preweaning lethality, complete penetrance 0.0
Snx25
Snx25tm1b(KOMP)Wtsi
Viability Primary Screen Outcome homozygote Male preweaning lethality, complete penetrance 0.0
Ctu2
Ctu2tm1(KOMP)Wtsi
Viability Primary Screen Outcome homozygote Female preweaning lethality, complete penetrance 0.0
Ctu2
Ctu2tm1(KOMP)Wtsi
Viability Primary Screen Outcome homozygote Male preweaning lethality, complete penetrance 0.0
Hnrnph1
Hnrnph1tm1b(KOMP)Wtsi
Viability Primary Screen Outcome homozygote Female preweaning lethality, complete penetrance 0.0
Hnrnph1
Hnrnph1tm1b(KOMP)Wtsi
Viability Primary Screen Outcome homozygote Male preweaning lethality, complete penetrance 0.0
Mir141
Mir141tm1(mirKO)Wtsi
Viability Primary Screen Outcome homozygote Female preweaning lethality, complete penetrance 0.0
Mir141
Mir141tm1(mirKO)Wtsi
Viability Primary Screen Outcome homozygote Male preweaning lethality, complete penetrance 0.0
Kdm1a
Kdm1atm1(NCOM)Mfgc
Viability Primary Screen Outcome homozygote Female preweaning lethality, complete penetrance 0.0
Kdm1a
Kdm1atm1(NCOM)Mfgc
Viability Primary Screen Outcome homozygote Male preweaning lethality, complete penetrance 0.0
Ehmt1
Ehmt1tm1b(EUCOMM)Hmgu
Viability Primary Screen Outcome homozygote Female preweaning lethality, complete penetrance 0.0
Ehmt1
Ehmt1tm1b(EUCOMM)Hmgu
Viability Primary Screen Outcome homozygote Male preweaning lethality, complete penetrance 0.0
Carm1
Carm1tm1b(EUCOMM)Hmgu
Viability Primary Screen Outcome homozygote Female preweaning lethality, complete penetrance 0.0
Carm1
Carm1tm1b(EUCOMM)Hmgu
Viability Primary Screen Outcome homozygote Male preweaning lethality, complete penetrance 0.0
Bnip1
Bnip1tm2b(KOMP)Wtsi
Viability Primary Screen Outcome homozygote Female preweaning lethality, complete penetrance 0.0
Bnip1
Bnip1tm2b(KOMP)Wtsi
Viability Primary Screen Outcome homozygote Male preweaning lethality, complete penetrance 0.0
Tsg101
Tsg101tm1b(EUCOMM)Hmgu
Viability Primary Screen Outcome homozygote Female preweaning lethality, complete penetrance 0.0
Tsg101
Tsg101tm1b(EUCOMM)Hmgu
Viability Primary Screen Outcome homozygote Male preweaning lethality, complete penetrance 0.0
Kmt2a
Kmt2aem1(IMPC)Marc
Viability Primary Screen Outcome homozygote Female preweaning lethality, complete penetrance 0.0
Kmt2a
Kmt2aem1(IMPC)Marc
Viability Primary Screen Outcome homozygote Male preweaning lethality, complete penetrance 0.0
Bap1
Bap1em2(IMPC)Marc
Viability Primary Screen Outcome homozygote Female preweaning lethality, complete penetrance 0.0
Bap1
Bap1em2(IMPC)Marc
Viability Primary Screen Outcome homozygote Male preweaning lethality, complete penetrance 0.0
Usp32
Usp32em1(IMPC)Mhzh
Viability Primary Screen Outcome homozygote Female preweaning lethality, complete penetrance 0.0
Usp32
Usp32em1(IMPC)Mhzh
Viability Primary Screen Outcome homozygote Male preweaning lethality, complete penetrance 0.0
Usp50
Usp50tm1(KOMP)Vlcg
Viability Primary Screen Outcome homozygote Female preweaning lethality, complete penetrance 0.0
Usp50
Usp50tm1(KOMP)Vlcg
Viability Primary Screen Outcome homozygote Male preweaning lethality, complete penetrance 0.0
Mir143
Mir143tm1(mirKO)Wtsi
Viability Primary Screen Outcome homozygote Female preweaning lethality, complete penetrance 0.0
Mir143
Mir143tm1(mirKO)Wtsi
Viability Primary Screen Outcome homozygote Male preweaning lethality, complete penetrance 0.0
Ppp2r2a
Ppp2r2atm1b(KOMP)Wtsi
Viability Primary Screen Outcome homozygote Female preweaning lethality, complete penetrance 0.0
Ppp2r2a
Ppp2r2atm1b(KOMP)Wtsi
Viability Primary Screen Outcome homozygote Male preweaning lethality, complete penetrance 0.0
Kdm5a
Kdm5aem1(IMPC)Marc
Viability Primary Screen Outcome homozygote Female preweaning lethality, complete penetrance 0.0
Kdm5a
Kdm5aem1(IMPC)Marc
Viability Primary Screen Outcome homozygote Male preweaning lethality, complete penetrance 0.0
Cyp3a41b
Cyp3a41btm1b(KOMP)Wtsi
Viability Primary Screen Outcome homozygote Female preweaning lethality, complete penetrance 0.0
Cyp3a41b
Cyp3a41btm1b(KOMP)Wtsi
Viability Primary Screen Outcome homozygote Male preweaning lethality, complete penetrance 0.0
Aars2
Aars2tm1(KOMP)Wtsi
Viability Primary Screen Outcome homozygote Female preweaning lethality, complete penetrance 0.0
Aars2
Aars2tm1(KOMP)Wtsi
Viability Primary Screen Outcome homozygote Male preweaning lethality, complete penetrance 0.0
Ufm1
Ufm1em1(IMPC)Marc
Viability Primary Screen Outcome homozygote Female preweaning lethality, complete penetrance 0.0
Ufm1
Ufm1em1(IMPC)Marc
Viability Primary Screen Outcome homozygote Male preweaning lethality, complete penetrance 0.0
Bod1
Bod1tm1b(KOMP)Wtsi
Viability Primary Screen Outcome homozygote Female preweaning lethality, complete penetrance 0.0
Bod1
Bod1tm1b(KOMP)Wtsi
Viability Primary Screen Outcome homozygote Male preweaning lethality, complete penetrance 0.0
Bend3
Bend3tm1b(KOMP)Mbp
Viability Primary Screen Outcome homozygote Female preweaning lethality, complete penetrance 0.0
Bend3
Bend3tm1b(KOMP)Mbp
Viability Primary Screen Outcome homozygote Male preweaning lethality, complete penetrance 0.0
Ash1l
Ash1ltm2b(EUCOMM)Hmgu
Viability Primary Screen Outcome homozygote Female preweaning lethality, complete penetrance 0.0
Ash1l
Ash1ltm2b(EUCOMM)Hmgu
Viability Primary Screen Outcome homozygote Male preweaning lethality, complete penetrance 0.0
Cyp3a59
Cyp3a59em1(IMPC)Marc
Viability Primary Screen Outcome homozygote Female preweaning lethality, complete penetrance 0.0
Cyp3a59
Cyp3a59em1(IMPC)Marc
Viability Primary Screen Outcome homozygote Male preweaning lethality, complete penetrance 0.0
Emc7
Emc7tm1b(KOMP)Mbp
Viability Primary Screen Outcome homozygote Female preweaning lethality, incomplete penetrance 0.0
Emc7
Emc7tm1b(KOMP)Mbp
Viability Primary Screen Outcome homozygote Male preweaning lethality, incomplete penetrance 0.0
Fbxw8
Fbxw8tm1b(EUCOMM)Hmgu
Viability Primary Screen Outcome homozygote Female preweaning lethality, incomplete penetrance 0.0
Fbxw8
Fbxw8tm1b(EUCOMM)Hmgu
Viability Primary Screen Outcome homozygote Male preweaning lethality, incomplete penetrance 0.0
Lhcgr
Lhcgrtm1(KOMP)Vlcg
Gross Pathology and Tissue Collection Stomach homozygote Male small stomach 0.0
Hectd3
Hectd3tm1(NCOM)Cmhd
Gross Pathology and Tissue Collection Stomach homozygote Male small stomach 0.0
Hectd3
Hectd3tm1(NCOM)Cmhd
Gross Pathology and Tissue Collection Stomach homozygote Female small stomach 0.0
Dagla
Daglatm1a(EUCOMM)Wtsi
Gross Pathology and Tissue Collection Stomach homozygote Male small stomach 0.0
Ccdc124
Ccdc124tm1b(KOMP)Wtsi
Gross Pathology and Tissue Collection Lung homozygote Male small lung 0.0
Ccdc124
Ccdc124tm1b(KOMP)Wtsi
Gross Pathology and Tissue Collection Lung homozygote Female small lung 0.0
Lhcgr
Lhcgrtm1(KOMP)Vlcg
Gross Pathology and Tissue Collection Lung homozygote Male small lung 0.0
Kdm1a
Kdm1atm1(NCOM)Mfgc
Gross Pathology and Tissue Collection Lung heterozygote Female small lung 0.0
Hectd3
Hectd3tm1(NCOM)Cmhd
Gross Pathology and Tissue Collection Lung homozygote Male small lung 0.0
Hectd3
Hectd3tm1(NCOM)Cmhd
Gross Pathology and Tissue Collection Lung homozygote Female small lung 0.0
Dagla
Daglatm1a(EUCOMM)Wtsi
Gross Pathology and Tissue Collection Lung homozygote Male small lung 0.0
Lhcgr
Lhcgrtm1(KOMP)Vlcg
Gross Pathology and Tissue Collection Thymus homozygote Male small thymus 0.0
Hectd3
Hectd3tm1(NCOM)Cmhd
Gross Pathology and Tissue Collection Thymus homozygote Male small thymus 0.0
Hectd3
Hectd3tm1(NCOM)Cmhd
Gross Pathology and Tissue Collection Thymus homozygote Female small thymus 0.0
Dagla
Daglatm1a(EUCOMM)Wtsi
Gross Pathology and Tissue Collection Thymus homozygote Male small thymus 0.0
Ccdc124
Ccdc124tm1b(KOMP)Wtsi
Gross Pathology and Tissue Collection Brain homozygote Male decreased brain size 0.0
Ccdc124
Ccdc124tm1b(KOMP)Wtsi
Gross Pathology and Tissue Collection Brain homozygote Female decreased brain size 0.0
Lhcgr
Lhcgrtm1(KOMP)Vlcg
Gross Pathology and Tissue Collection Brain homozygote Male decreased brain size 0.0
Hectd3
Hectd3tm1(NCOM)Cmhd
Gross Pathology and Tissue Collection Brain homozygote Male decreased brain size 0.0
Hectd3
Hectd3tm1(NCOM)Cmhd
Gross Pathology and Tissue Collection Brain homozygote Female decreased brain size 0.0
Dagla
Daglatm1a(EUCOMM)Wtsi
Gross Pathology and Tissue Collection Brain homozygote Male decreased brain size 0.0
Spata16
Spata16em1(IMPC)Marc
Fertility of Homozygous Knock-out Mice Gross Findings Female homozygote Female female infertility 0.0
Fbxo38
Fbxo38em2(IMPC)Marc
Fertility of Homozygous Knock-out Mice Gross Findings Female homozygote Female female infertility 0.0
Erich2
Erich2em1(IMPC)Marc
Fertility of Homozygous Knock-out Mice Gross Findings Female homozygote Female female infertility 0.0
Dctd
Dctdem1(IMPC)Marc
Fertility of Homozygous Knock-out Mice Gross Findings Female homozygote Female female infertility 0.0
Hectd3
Hectd3tm1(NCOM)Cmhd
Fertility of Homozygous Knock-out Mice Gross Findings Female homozygote Female female infertility 0.0
Fbxo43
Fbxo43em1(IMPC)Marc
Fertility of Homozygous Knock-out Mice Gross Findings Female homozygote Female female infertility 0.0
Skp2
Skp2em2(IMPC)Marc
Fertility of Homozygous Knock-out Mice Gross Findings Female homozygote Female female infertility 0.0
Usp15
Usp15em1(IMPC)Marc
Fertility of Homozygous Knock-out Mice Gross Findings Female homozygote Female female infertility 0.0
Bbof1
Bbof1em1(IMPC)Marc
Fertility of Homozygous Knock-out Mice Gross Findings Female homozygote Female female infertility 0.0
Fbxo22
Fbxo22tm1b(EUCOMM)Wtsi
Fertility of Homozygous Knock-out Mice Gross Findings Female homozygote Female female infertility 0.0
Trim37
Trim37em1(IMPC)Marc
Fertility of Homozygous Knock-out Mice Gross Findings Female homozygote Female female infertility 0.0
Fbxo24
Fbxo24em2(IMPC)Marc
Fertility of Homozygous Knock-out Mice Gross Findings Female homozygote Female female infertility 0.0
Dusp7
Dusp7tm1(KOMP)Wtsi
Fertility of Homozygous Knock-out Mice Gross Findings Female homozygote Female female infertility 0.0
Jade1
Jade1tm1b(KOMP)Wtsi
Fertility of Homozygous Knock-out Mice Gross Findings Female homozygote Female female infertility 0.0
Hoxc11
Hoxc11em1(IMPC)Marc
Fertility of Homozygous Knock-out Mice Gross Findings Male homozygote Male male infertility 0.0
Ezh1
Ezh1tm1b(EUCOMM)Wtsi
Fertility of Homozygous Knock-out Mice Gross Findings Male homozygote Male male infertility 0.0
Spata16
Spata16em1(IMPC)Marc
Fertility of Homozygous Knock-out Mice Gross Findings Male homozygote Male male infertility 0.0
Maob
Maobem1(IMPC)Marc
Fertility of Homozygous Knock-out Mice Gross Findings Male homozygote Male male infertility 0.0
Fbxo38
Fbxo38em2(IMPC)Marc
Fertility of Homozygous Knock-out Mice Gross Findings Male homozygote Male male infertility 0.0
Ppp2r1b
Ppp2r1btm1b(EUCOMM)Wtsi
Fertility of Homozygous Knock-out Mice Gross Findings Male homozygote Male male infertility 0.0
Erich2
Erich2em1(IMPC)Marc
Fertility of Homozygous Knock-out Mice Gross Findings Male homozygote Male male infertility 0.0
Dctd
Dctdem1(IMPC)Marc
Fertility of Homozygous Knock-out Mice Gross Findings Male homozygote Male male infertility 0.0
Hectd3
Hectd3tm1(NCOM)Cmhd
Fertility of Homozygous Knock-out Mice Gross Findings Male homozygote Male male infertility 0.0
Prmt6
Prmt6em1(IMPC)Marc
Fertility of Homozygous Knock-out Mice Gross Findings Male homozygote Male male infertility 0.0
Fbxo43
Fbxo43em1(IMPC)Marc
Fertility of Homozygous Knock-out Mice Gross Findings Male homozygote Male male infertility 0.0
Skp2
Skp2em2(IMPC)Marc
Fertility of Homozygous Knock-out Mice Gross Findings Male homozygote Male male infertility 0.0
Usp15
Usp15em1(IMPC)Marc
Fertility of Homozygous Knock-out Mice Gross Findings Male homozygote Male male infertility 0.0
Bbof1
Bbof1em1(IMPC)Marc
Fertility of Homozygous Knock-out Mice Gross Findings Male homozygote Male male infertility 0.0
Fbxo22
Fbxo22tm1b(EUCOMM)Wtsi
Fertility of Homozygous Knock-out Mice Gross Findings Male homozygote Male male infertility 0.0
Trim37
Trim37em1(IMPC)Marc
Fertility of Homozygous Knock-out Mice Gross Findings Male homozygote Male male infertility 0.0
Fbxo24
Fbxo24em2(IMPC)Marc
Fertility of Homozygous Knock-out Mice Gross Findings Male homozygote Male male infertility 0.0
Dusp7
Dusp7tm1(KOMP)Wtsi
Fertility of Homozygous Knock-out Mice Gross Findings Male homozygote Male male infertility 0.0
Jade1
Jade1tm1b(KOMP)Wtsi
Fertility of Homozygous Knock-out Mice Gross Findings Male homozygote Male male infertility 0.0
Ccdc124
Ccdc124tm1b(KOMP)Wtsi
Gross Pathology and Tissue Collection Liver homozygote Male small liver 0.0
Ccdc124
Ccdc124tm1b(KOMP)Wtsi
Gross Pathology and Tissue Collection Liver homozygote Female small liver 0.0
Lhcgr
Lhcgrtm1(KOMP)Vlcg
Gross Pathology and Tissue Collection Liver homozygote Male small liver 0.0
Kdm1a
Kdm1atm1(NCOM)Mfgc
Gross Pathology and Tissue Collection Liver heterozygote Female small liver 0.0
Hectd3
Hectd3tm1(NCOM)Cmhd
Gross Pathology and Tissue Collection Liver homozygote Male small liver 0.0
Hectd3
Hectd3tm1(NCOM)Cmhd
Gross Pathology and Tissue Collection Liver homozygote Female small liver 0.0
Dagla
Daglatm1a(EUCOMM)Wtsi
Gross Pathology and Tissue Collection Liver homozygote Male small liver 0.0
Fbxo38
Fbxo38em2(IMPC)Marc
Gross Pathology and Tissue Collection Liver homozygote Female small liver 0.0
Ccdc124
Ccdc124tm1b(KOMP)Wtsi
Gross Pathology and Tissue Collection Spleen homozygote Male small spleen 0.0
Ccdc124
Ccdc124tm1b(KOMP)Wtsi
Gross Pathology and Tissue Collection Spleen homozygote Female small spleen 0.0
Lhcgr
Lhcgrtm1(KOMP)Vlcg
Gross Pathology and Tissue Collection Spleen homozygote Male small spleen 0.0
Kdm1a
Kdm1atm1(NCOM)Mfgc
Gross Pathology and Tissue Collection Spleen heterozygote Female small spleen 0.0
Hectd3
Hectd3tm1(NCOM)Cmhd
Gross Pathology and Tissue Collection Spleen homozygote Male small spleen 0.0
Hectd3
Hectd3tm1(NCOM)Cmhd
Gross Pathology and Tissue Collection Spleen homozygote Female small spleen 0.0
Dagla
Daglatm1a(EUCOMM)Wtsi
Gross Pathology and Tissue Collection Spleen homozygote Male small spleen 0.0
Fbxl5
Fbxl5em1(IMPC)Marc
Gross Pathology and Tissue Collection Spleen heterozygote Female enlarged spleen 0.0
Kmt2c
Kmt2cem2(IMPC)Marc
Gross Pathology and Tissue Collection Spleen heterozygote Female enlarged spleen 0.0
Fbxo15
Fbxo15em1(IMPC)Marc
Gross Pathology and Tissue Collection Spleen homozygote Female enlarged spleen 0.0
Tsg101
Tsg101tm1b(EUCOMM)Hmgu
Gross Pathology and Tissue Collection Kidney heterozygote Female abnormal kidney morphology 0.0
Ccdc124
Ccdc124tm1b(KOMP)Wtsi
Gross Pathology and Tissue Collection Heart homozygote Male small heart 0.0
Ccdc124
Ccdc124tm1b(KOMP)Wtsi
Gross Pathology and Tissue Collection Heart homozygote Female small heart 0.0
Lhcgr
Lhcgrtm1(KOMP)Vlcg
Gross Pathology and Tissue Collection Heart homozygote Male small heart 0.0
Kdm1a
Kdm1atm1(NCOM)Mfgc
Gross Pathology and Tissue Collection Heart heterozygote Female small heart 0.0
Hectd3
Hectd3tm1(NCOM)Cmhd
Gross Pathology and Tissue Collection Heart homozygote Male small heart 0.0
Hectd3
Hectd3tm1(NCOM)Cmhd
Gross Pathology and Tissue Collection Heart homozygote Female small heart 0.0
Dagla
Daglatm1a(EUCOMM)Wtsi
Gross Pathology and Tissue Collection Heart homozygote Male small heart 0.0
Mir429
Mir429tm1(mirKO)Wtsi
Open Field Periphery permanence time heterozygote Female abnormal behavior 0.0
Mir28a
Mir28atm1(mirKO)Wtsi
Clinical Chemistry Alkaline phosphatase homozygote Female increased circulating alkaline phosphatase level 0.0
Mir28a
Mir28atm1(mirKO)Wtsi
Clinical Chemistry Alkaline phosphatase homozygote Male increased circulating alkaline phosphatase level 0.0
Hectd3
Hectd3tm1(NCOM)Cmhd
Body Composition (DEXA lean/fat) Bone Mineral Density (excluding skull) homozygote Female decreased bone mineral density 1.401298464324817E-45
Hectd3
Hectd3tm1(NCOM)Cmhd
Body Composition (DEXA lean/fat) Bone Mineral Density (excluding skull) homozygote Male decreased bone mineral density 1.401298464324817E-45
Mir28a
Mir28atm1(mirKO)Wtsi
Clinical Chemistry Creatinine homozygote Female increased circulating creatinine level 1.6815581571897805E-44
Mir28a
Mir28atm1(mirKO)Wtsi
Clinical Chemistry Creatinine homozygote Male increased circulating creatinine level 1.6815581571897805E-44
Hectd3
Hectd3tm1(NCOM)Cmhd
Body Composition (DEXA lean/fat) Bone Mineral Content (excluding skull) homozygote Female decreased bone mineral content 1.2373013661363236E-37
Hectd3
Hectd3tm1(NCOM)Cmhd
Body Composition (DEXA lean/fat) Bone Mineral Content (excluding skull) homozygote Male decreased bone mineral content 1.2373013661363236E-37
Hectd3
Hectd3tm1(NCOM)Cmhd
Body Composition (DEXA lean/fat) Lean mass homozygote Female decreased lean body mass 3.907997209247623E-37
Hectd3
Hectd3tm1(NCOM)Cmhd
Body Composition (DEXA lean/fat) Lean mass homozygote Male decreased lean body mass 3.907997209247623E-37
Prdm2
Prdm2em1(IMPC)Marc
Hematology Mean cell hemoglobin concentration homozygote Female increased mean corpuscular hemoglobin concentration 2.5548627856505018E-36
Prdm2
Prdm2em1(IMPC)Marc
Hematology Mean cell hemoglobin concentration homozygote Male increased mean corpuscular hemoglobin concentration 2.5548627856505018E-36
Hectd3
Hectd3tm1(NCOM)Cmhd
Body Composition (DEXA lean/fat) Bone Area homozygote Female abnormal bone structure 2.559068834155382E-32
Hectd3
Hectd3tm1(NCOM)Cmhd
Body Composition (DEXA lean/fat) Bone Area homozygote Male abnormal bone structure 2.559068834155382E-32
Cyp17a1
Cyp17a1tm1b(EUCOMM)Wtsi
Body Composition (DEXA lean/fat) BMC/Body weight homozygote Female decreased bone mineral content 3.142690165454462E-30
Cyp17a1
Cyp17a1tm1b(EUCOMM)Wtsi
Body Composition (DEXA lean/fat) BMC/Body weight homozygote Male decreased bone mineral content 3.142690165454462E-30
Cyp17a1
Cyp17a1tm1b(EUCOMM)Wtsi
Intraperitoneal glucose tolerance test (IPGTT) Fasted blood glucose concentration homozygote Female increased fasted circulating glucose level 1.7958791174800573E-29
Cyp17a1
Cyp17a1tm1b(EUCOMM)Wtsi
Intraperitoneal glucose tolerance test (IPGTT) Fasted blood glucose concentration homozygote Male increased fasted circulating glucose level 1.7958791174800573E-29
Wfdc11
Wfdc11em1(IMPC)Marc
Echo LVIDd homozygote Female abnormal heart left ventricle morphology 6.728253112603822E-29
Wfdc11
Wfdc11em1(IMPC)Marc
Echo LVIDd homozygote Male abnormal heart left ventricle morphology 6.728253112603822E-29
Cyp17a1
Cyp17a1tm1b(EUCOMM)Wtsi
Body Composition (DEXA lean/fat) Fat/Body weight homozygote Female increased total body fat amount 1.7197025215002173E-27
Cyp17a1
Cyp17a1tm1b(EUCOMM)Wtsi
Body Composition (DEXA lean/fat) Fat/Body weight homozygote Male increased total body fat amount 1.7197025215002173E-27
Fbxo36
Fbxo36tm1b(KOMP)Wtsi
Hematology Mean cell volume homozygote Female decreased mean corpuscular volume 8.592272979667261E-26
Fbxo36
Fbxo36tm1b(KOMP)Wtsi
Hematology Mean cell volume homozygote Male decreased mean corpuscular volume 8.592272979667261E-26
Cyp17a1
Cyp17a1tm1b(EUCOMM)Wtsi
Body Composition (DEXA lean/fat) Fat mass homozygote Female increased total body fat amount 1.2543748744438844E-25
Cyp17a1
Cyp17a1tm1b(EUCOMM)Wtsi
Body Composition (DEXA lean/fat) Fat mass homozygote Male increased total body fat amount 1.2543748744438844E-25
Usp31
Usp31em1(IMPC)Marc
Clinical Chemistry Phosphorus homozygote Female increased circulating phosphate level 5.506243695023939E-25
Usp31
Usp31em1(IMPC)Marc
Clinical Chemistry Phosphorus homozygote Male increased circulating phosphate level 5.506243695023939E-25
Wfdc11
Wfdc11em1(IMPC)Marc
Echo HR homozygote Female decreased heart rate 2.7426415838670755E-24
Wfdc11
Wfdc11em1(IMPC)Marc
Echo HR homozygote Male decreased heart rate 2.7426415838670755E-24
Cyp17a1
Cyp17a1tm1b(EUCOMM)Wtsi
Body Composition (DEXA lean/fat) Lean/Body weight homozygote Female decreased lean body mass 5.546776453017939E-24
Cyp17a1
Cyp17a1tm1b(EUCOMM)Wtsi
Body Composition (DEXA lean/fat) Lean/Body weight homozygote Male decreased lean body mass 5.546776453017939E-24
Phf5a
Phf5aem2(IMPC)Marc
Body Composition (DEXA lean/fat) BMC/Body weight heterozygote Female increased bone mineral content 2.2340645849022757E-21
Phf5a
Phf5aem2(IMPC)Marc
Body Composition (DEXA lean/fat) BMC/Body weight heterozygote Male increased bone mineral content 2.2340645849022757E-21
Cyp17a1
Cyp17a1tm1b(EUCOMM)Wtsi
Body Composition (DEXA lean/fat) Bone Mineral Content (excluding skull) homozygote Female decreased bone mineral content 1.4921268731773982E-20
Cyp17a1
Cyp17a1tm1b(EUCOMM)Wtsi
Body Composition (DEXA lean/fat) Bone Mineral Content (excluding skull) homozygote Male decreased bone mineral content 1.4921268731773982E-20
Atg4c
Atg4cem2(IMPC)Marc
Hematology Mean cell volume homozygote Female decreased mean corpuscular volume 2.0234472291937462E-17
Cyp17a1
Cyp17a1tm1b(EUCOMM)Wtsi
Body Composition (DEXA lean/fat) Bone Mineral Density (excluding skull) homozygote Female decreased bone mineral density 6.568296475404281E-17
Cyp17a1
Cyp17a1tm1b(EUCOMM)Wtsi
Body Composition (DEXA lean/fat) Bone Mineral Density (excluding skull) homozygote Male decreased bone mineral density 6.568296475404281E-17
Fbxo15
Fbxo15em1(IMPC)Marc
Hematology Neutrophil differential count homozygote Male increased neutrophil cell number 3.5463739548276577E-16
AW112010
AW112010em1(IMPC)Marc
Hematology Mean cell volume homozygote Male decreased mean corpuscular volume 6.361500131125942E-16
Trim37
Trim37em1(IMPC)Marc
Body Composition (DEXA lean/fat) BMC/Body weight homozygote Female decreased bone mineral content 1.5987327598116028E-15
Hectd3
Hectd3tm1(NCOM)Cmhd
Body Composition (DEXA lean/fat) BMC/Body weight homozygote Female decreased bone mineral content 1.8860620056297857E-15
Hectd3
Hectd3tm1(NCOM)Cmhd
Body Composition (DEXA lean/fat) BMC/Body weight homozygote Male decreased bone mineral content 1.8860620056297857E-15
Phf5a
Phf5aem2(IMPC)Marc
Hematology Mean platelet volume heterozygote Female increased mean platelet volume 3.48192374726667E-15
Phf5a
Phf5aem2(IMPC)Marc
Hematology Mean platelet volume heterozygote Male increased mean platelet volume 3.48192374726667E-15
Cyp17a1
Cyp17a1tm1b(EUCOMM)Wtsi
Body Composition (DEXA lean/fat) Lean mass homozygote Male decreased lean body mass 4.988738609224604E-15
Ehmt1
Ehmt1tm1b(EUCOMM)Hmgu
Open Field Periphery resting time heterozygote Female hypoactivity 1.1310538517870974E-14
Ehmt1
Ehmt1tm1b(EUCOMM)Hmgu
Open Field Periphery resting time heterozygote Male hypoactivity 1.1310538517870974E-14
Tmem63a
Tmem63atm1(KOMP)Vlcg
Clinical Chemistry Creatinine homozygote Female increased circulating creatinine level 1.3315461268857166E-14
Tmem63a
Tmem63atm1(KOMP)Vlcg
Clinical Chemistry Creatinine homozygote Male increased circulating creatinine level 1.3315461268857166E-14
Fshr
Fshrtm1(KOMP)Vlcg
Body Composition (DEXA lean/fat) BMC/Body weight homozygote Female decreased bone mineral content 3.1006115372694126E-14
Ehmt1
Ehmt1tm1b(EUCOMM)Hmgu
Open Field Whole arena resting time heterozygote Female hypoactivity 5.76165431012167E-14
Ehmt1
Ehmt1tm1b(EUCOMM)Hmgu
Open Field Whole arena resting time heterozygote Male hypoactivity 5.76165431012167E-14
Cyp17a1
Cyp17a1tm1b(EUCOMM)Wtsi
Combined SHIRPA and Dysmorphology Genitalia - size homozygote Male abnormal male genitalia morphology 1.0607670070019587E-13
Cyp17a1
Cyp17a1tm1b(EUCOMM)Wtsi
Combined SHIRPA and Dysmorphology Genitalia - presence homozygote Male absent external male genitalia 1.0607670070019587E-13
Fbxo15
Fbxo15em1(IMPC)Marc
Hematology Lymphocyte differential count homozygote Male decreased lymphocyte cell number 1.4667993653450645E-13
Ppp2r5e
Ppp2r5eem1(IMPC)Marc
Hematology Mean cell volume homozygote Female increased mean corpuscular volume 1.5092094240998222E-13
Ppp2r5e
Ppp2r5eem1(IMPC)Marc
Hematology Mean cell volume homozygote Male increased mean corpuscular volume 1.5092094240998222E-13
Cyp17a1
Cyp17a1tm1b(EUCOMM)Wtsi
Combined SHIRPA and Dysmorphology Genitalia - morphology homozygote Male abnormal male genitalia morphology 2.5066718991294257E-13
Hnrnph1
Hnrnph1tm1b(KOMP)Wtsi
Hematology Mean cell volume heterozygote Female increased mean corpuscular volume 4.1472725319062487E-13
Hnrnph1
Hnrnph1tm1b(KOMP)Wtsi
Hematology Mean cell volume heterozygote Male increased mean corpuscular volume 4.1472725319062487E-13
Fbxw13
Fbxw13em2(IMPC)Marc
Hematology Mean cell volume homozygote Female increased mean corpuscular volume 6.872923996419089E-13
Fbxw13
Fbxw13em2(IMPC)Marc
Hematology Mean cell volume homozygote Male increased mean corpuscular volume 6.872923996419089E-13
Dlgap2
Dlgap2em1(IMPC)Mhzh
Hematology Lymphocyte differential count homozygote Male decreased lymphocyte cell number 7.661627950995842E-13
Wfdc11
Wfdc11em1(IMPC)Marc
Echo LVPWd homozygote Female thick ventricular wall 1.2756399669217044E-12
Wfdc11
Wfdc11em1(IMPC)Marc
Echo LVPWd homozygote Male thick ventricular wall 1.2756399669217044E-12
Cyp17a1
Cyp17a1tm1b(EUCOMM)Wtsi
Body Composition (DEXA lean/fat) Bone Area homozygote Female abnormal bone structure 1.383512336812498E-12
Cyp17a1
Cyp17a1tm1b(EUCOMM)Wtsi
Body Composition (DEXA lean/fat) Bone Area homozygote Male abnormal bone structure 1.383512336812498E-12
Hectd3
Hectd3tm1(NCOM)Cmhd
Grip Strength Forelimb and hindlimb grip strength measurement mean homozygote Female decreased grip strength 1.5026105359972064E-12
Hectd3
Hectd3tm1(NCOM)Cmhd
Grip Strength Forelimb and hindlimb grip strength measurement mean homozygote Male decreased grip strength 1.5026105359972064E-12
Trim37
Trim37em1(IMPC)Marc
Hematology Lymphocyte cell count homozygote Female decreased lymphocyte cell number 1.956499198763062E-12
Trim37
Trim37em1(IMPC)Marc
Hematology Lymphocyte cell count homozygote Male decreased lymphocyte cell number 1.956499198763062E-12
Usp32
Usp32em1(IMPC)Mhzh
Clinical Chemistry Glucose heterozygote Female decreased circulating glucose level 2.154776357343735E-12
Usp32
Usp32em1(IMPC)Mhzh
Clinical Chemistry Glucose heterozygote Male decreased circulating glucose level 2.154776357343735E-12
Phf5a
Phf5aem2(IMPC)Marc
Body Composition (DEXA lean/fat) Fat mass heterozygote Female decreased total body fat amount 2.7878112145163225E-12
Phf5a
Phf5aem2(IMPC)Marc
Body Composition (DEXA lean/fat) Fat mass heterozygote Male decreased total body fat amount 2.7878112145163225E-12
Wfdc11
Wfdc11em1(IMPC)Marc
Echo LVIDs homozygote Female abnormal heart left ventricle morphology 3.683734307174946E-12
Wfdc11
Wfdc11em1(IMPC)Marc
Echo LVIDs homozygote Male abnormal heart left ventricle morphology 3.683734307174946E-12
Brcc3
Brcc3em1(IMPC)Marc
Hematology Mean cell volume homozygote Female increased mean corpuscular volume 3.949800556068972E-12
Brcc3
Brcc3em1(IMPC)Marc
Hematology Mean cell volume homozygote Male increased mean corpuscular volume 3.949800556068972E-12
Fbxo38
Fbxo38em2(IMPC)Marc
Body Composition (DEXA lean/fat) Body length homozygote Female decreased body length 4.006222870805987E-12
Fbxo38
Fbxo38em2(IMPC)Marc
Body Composition (DEXA lean/fat) Body length homozygote Male decreased body length 4.006222870805987E-12
Wfdc11
Wfdc11em1(IMPC)Marc
Echo LVAWd homozygote Female increased heart left ventricle size 5.186417267877275E-12
Wfdc11
Wfdc11em1(IMPC)Marc
Echo LVAWd homozygote Male increased heart left ventricle size 5.186417267877275E-12
Ash1l
Ash1ltm2b(EUCOMM)Hmgu
Eye Morphology Pupil Light Response heterozygote Female impaired pupillary reflex 7.755900956196715E-12
Hnrnph1
Hnrnph1tm1b(KOMP)Wtsi
Hematology Mean cell hemoglobin concentration heterozygote Female decreased mean corpuscular hemoglobin concentration 1.1059823196157836E-11
Hnrnph1
Hnrnph1tm1b(KOMP)Wtsi
Hematology Mean cell hemoglobin concentration heterozygote Male decreased mean corpuscular hemoglobin concentration 1.1059823196157836E-11
Ankle1
Ankle1tm1(KOMP)Wtsi
Combined SHIRPA and Dysmorphology Coat - color - head homozygote Female abnormal coat/hair pigmentation 1.2560750183021607E-11
Gsdma3
Gsdma3tm1(KOMP)Vlcg
Clinical Chemistry Alkaline phosphatase homozygote Female increased circulating alkaline phosphatase level 1.43067250754636E-11
Gsdma3
Gsdma3tm1(KOMP)Vlcg
Clinical Chemistry Alkaline phosphatase homozygote Male increased circulating alkaline phosphatase level 1.43067250754636E-11
Zdhhc2
Zdhhc2tm1b(KOMP)Wtsi
Combined SHIRPA and Dysmorphology Lower lip morphology homozygote Male abnormal lip morphology 1.5653360552203566E-11
Ankle1
Ankle1tm1(KOMP)Wtsi
Combined SHIRPA and Dysmorphology Coat - color - abdomen homozygote Female abnormal coat/hair pigmentation 1.7732820420390816E-11
Usp47
Usp47tm1b(EUCOMM)Wtsi
Clinical Chemistry HDL-cholesterol homozygote Male increased circulating HDL cholesterol level 2.0314564266876722E-11
Cpa1
Cpa1em1(IMPC)Marc
Hematology Mean cell volume homozygote Female increased mean corpuscular volume 3.5219185207102655E-11
Cpa1
Cpa1em1(IMPC)Marc
Hematology Mean cell volume homozygote Male increased mean corpuscular volume 3.5219185207102655E-11
Ube2w
Ube2wtm1b(EUCOMM)Wtsi
Intraperitoneal glucose tolerance test (IPGTT) Fasted blood glucose concentration homozygote Female increased fasted circulating glucose level 5.7756611993031726E-11
Ube2w
Ube2wtm1b(EUCOMM)Wtsi
Intraperitoneal glucose tolerance test (IPGTT) Fasted blood glucose concentration homozygote Male increased fasted circulating glucose level 5.7756611993031726E-11
Dagla
Daglatm1a(EUCOMM)Wtsi
Body Composition (DEXA lean/fat) Bone Area homozygote Female abnormal bone structure 6.309883865407429E-11
Dagla
Daglatm1a(EUCOMM)Wtsi
Body Composition (DEXA lean/fat) Bone Area homozygote Male abnormal bone structure 6.309883865407429E-11
Fbxo38
Fbxo38em2(IMPC)Marc
Hematology Red blood cell distribution width homozygote Female increased red blood cell distribution width 7.805065621591112E-11
Fbxo38
Fbxo38em2(IMPC)Marc
Hematology Red blood cell distribution width homozygote Male increased red blood cell distribution width 7.805065621591112E-11
Ankle1
Ankle1tm1(KOMP)Wtsi
Combined SHIRPA and Dysmorphology Coat - color - back homozygote Female abnormal coat/hair pigmentation 1.0430530050786757E-10
Prdm2
Prdm2em1(IMPC)Marc
Hematology Mean corpuscular hemoglobin homozygote Female increased mean corpuscular hemoglobin 1.1005236305594579E-10
Prdm2
Prdm2em1(IMPC)Marc
Hematology Mean corpuscular hemoglobin homozygote Male increased mean corpuscular hemoglobin 1.1005236305594579E-10
Wfdc11
Wfdc11em1(IMPC)Marc
Echo LVPWs homozygote Female thick ventricular wall 1.4031226180932777E-10
Wfdc11
Wfdc11em1(IMPC)Marc
Echo LVPWs homozygote Male thick ventricular wall 1.4031226180932777E-10
Dagla
Daglatm1a(EUCOMM)Wtsi
Body Composition (DEXA lean/fat) Bone Mineral Content (excluding skull) homozygote Female decreased bone mineral content 1.4833441419614957E-10
Dagla
Daglatm1a(EUCOMM)Wtsi
Body Composition (DEXA lean/fat) Bone Mineral Content (excluding skull) homozygote Male decreased bone mineral content 1.4833441419614957E-10
Fbxo36
Fbxo36tm1b(KOMP)Wtsi
Hematology Mean platelet volume homozygote Female decreased mean platelet volume 1.6403843561274556E-10
Fbxo36
Fbxo36tm1b(KOMP)Wtsi
Hematology Mean platelet volume homozygote Male decreased mean platelet volume 1.6403843561274556E-10
Fbxo36
Fbxo36tm1b(KOMP)Wtsi
Hematology Mean cell hemoglobin concentration homozygote Female increased mean corpuscular hemoglobin concentration 1.6418108539362208E-10
Fbxo36
Fbxo36tm1b(KOMP)Wtsi
Hematology Mean cell hemoglobin concentration homozygote Male increased mean corpuscular hemoglobin concentration 1.6418108539362208E-10
Fbxo36
Fbxo36tm1b(KOMP)Wtsi
Hematology Hematocrit homozygote Female decreased hematocrit 1.7230263049672345E-10
Fbxo36
Fbxo36tm1b(KOMP)Wtsi
Hematology Hematocrit homozygote Male decreased hematocrit 1.7230263049672345E-10
Fancl
Fancltm1b(EUCOMM)Hmgu
Body Composition (DEXA lean/fat) BMC/Body weight homozygote Female decreased bone mineral content 1.8755569319850451E-10
Hnrnpr
Hnrnprem1(IMPC)Marc
Hematology Lymphocyte cell count homozygote Female increased lymphocyte cell number 2.8670371632344427E-10
Hnrnpr
Hnrnprem1(IMPC)Marc
Hematology Lymphocyte cell count homozygote Male increased lymphocyte cell number 2.8670371632344427E-10
Ehmt1
Ehmt1tm1b(EUCOMM)Hmgu
Open Field Center permanence time heterozygote Female abnormal behavior 3.197105358232477E-10
Ehmt1
Ehmt1tm1b(EUCOMM)Hmgu
Open Field Center permanence time heterozygote Male abnormal behavior 3.197105358232477E-10
Ehmt1
Ehmt1tm1b(EUCOMM)Hmgu
Open Field Percentage center time heterozygote Female abnormal behavior 3.2054989218543994E-10
Ehmt1
Ehmt1tm1b(EUCOMM)Hmgu
Open Field Percentage center time heterozygote Male abnormal behavior 3.2054989218543994E-10
Ehmt1
Ehmt1tm1b(EUCOMM)Hmgu
Open Field Periphery permanence time heterozygote Female abnormal behavior 3.257695502245639E-10
Ehmt1
Ehmt1tm1b(EUCOMM)Hmgu
Open Field Periphery permanence time heterozygote Male abnormal behavior 3.257695502245639E-10
Eddm3b
Eddm3btm1b(KOMP)Wtsi
Eye Morphology Iris Pigmentation homozygote Male abnormal iris pigmentation 3.5388308949890757E-10
Trim37
Trim37em1(IMPC)Marc
Intraperitoneal glucose tolerance test (IPGTT) Area under glucose response curve homozygote Male improved glucose tolerance 3.6889893917368966E-10
Mir28a
Mir28atm1(mirKO)Wtsi
Clinical Chemistry Triglycerides homozygote Male increased circulating triglyceride level 4.215483795366737E-10
Fbxo22
Fbxo22tm1b(EUCOMM)Wtsi
Combined SHIRPA and Dysmorphology Tail - morphology homozygote Female abnormal tail morphology 4.5532189130170764E-10
Hnrnpr
Hnrnprem1(IMPC)Marc
Hematology Mean cell volume homozygote Female increased mean corpuscular volume 5.499535826736235E-10
Hnrnpr
Hnrnprem1(IMPC)Marc
Hematology Mean cell volume homozygote Male increased mean corpuscular volume 5.499535826736235E-10
Usp47
Usp47tm1b(EUCOMM)Wtsi
Clinical Chemistry Total cholesterol homozygote Male increased circulating cholesterol level 6.274251673765718E-10
Etaa1
Etaa1em1(IMPC)Marc
Hematology Hemoglobin homozygote Male decreased hemoglobin content 6.47299325251538E-10
Fbxo36
Fbxo36tm1b(KOMP)Wtsi
Hematology Platelet count homozygote Female thrombocytopenia 6.775776051348714E-10
Fbxo36
Fbxo36tm1b(KOMP)Wtsi
Hematology Platelet count homozygote Male thrombocytopenia 6.775776051348714E-10
Atg4b
Atg4bem1(IMPC)Marc
Clinical Chemistry Urea (Blood Urea Nitrogen - BUN) homozygote Female decreased blood urea nitrogen level 7.049990591312394E-10
Atg4b
Atg4bem1(IMPC)Marc
Clinical Chemistry Urea (Blood Urea Nitrogen - BUN) homozygote Male decreased blood urea nitrogen level 7.049990591312394E-10
Ehmt1
Ehmt1tm1b(EUCOMM)Hmgu
Open Field Center distance travelled heterozygote Female abnormal behavior 7.532840462509682E-10
Ehmt1
Ehmt1tm1b(EUCOMM)Hmgu
Open Field Center distance travelled heterozygote Male abnormal behavior 7.532840462509682E-10
Cpa1
Cpa1em1(IMPC)Marc
Hematology Mean corpuscular hemoglobin homozygote Female increased mean corpuscular hemoglobin 9.38112698634086E-10
Cpa1
Cpa1em1(IMPC)Marc
Hematology Mean corpuscular hemoglobin homozygote Male increased mean corpuscular hemoglobin 9.38112698634086E-10
Cyp17a1
Cyp17a1tm1b(EUCOMM)Wtsi
Open Field Periphery resting time homozygote Female hypoactivity 9.525215061145786E-10
Cyp17a1
Cyp17a1tm1b(EUCOMM)Wtsi
Open Field Periphery resting time homozygote Male hypoactivity 9.525215061145786E-10
Fbxo38
Fbxo38em2(IMPC)Marc
Body Composition (DEXA lean/fat) Lean mass homozygote Female decreased lean body mass 1.088352852285368E-9
Fbxo38
Fbxo38em2(IMPC)Marc
Body Composition (DEXA lean/fat) Lean mass homozygote Male decreased lean body mass 1.088352852285368E-9
Ehmt1
Ehmt1tm1b(EUCOMM)Hmgu
Open Field Number of center entries heterozygote Female abnormal behavior 1.3546634924921364E-9
Ehmt1
Ehmt1tm1b(EUCOMM)Hmgu
Open Field Number of center entries heterozygote Male abnormal behavior 1.3546634924921364E-9
Etaa1
Etaa1em1(IMPC)Marc
Hematology Red blood cell distribution width homozygote Female increased red blood cell distribution width 1.4967552752764846E-9
Etaa1
Etaa1em1(IMPC)Marc
Hematology Red blood cell distribution width homozygote Male increased red blood cell distribution width 1.4967552752764846E-9
Trim37
Trim37em1(IMPC)Marc
Hematology White blood cell count homozygote Female decreased leukocyte cell number 1.680150352179055E-9
Trim37
Trim37em1(IMPC)Marc
Hematology White blood cell count homozygote Male decreased leukocyte cell number 1.680150352179055E-9
Ufm1
Ufm1em1(IMPC)Marc
Clinical Chemistry Urea (Blood Urea Nitrogen - BUN) heterozygote Male increased blood urea nitrogen level 2.2002535349230357E-9
Ufm1
Ufm1em1(IMPC)Marc
Clinical Chemistry Urea (Blood Urea Nitrogen - BUN) heterozygote Female decreased blood urea nitrogen level 2.2002535349230357E-9
Ppp2r2a
Ppp2r2atm1b(KOMP)Wtsi
Open Field Distance travelled - total heterozygote Female hypoactivity 2.3668185189507085E-9
Ppp2r2a
Ppp2r2atm1b(KOMP)Wtsi
Open Field Distance travelled - total heterozygote Male hypoactivity 2.3668185189507085E-9
Usp31
Usp31em1(IMPC)Marc
Acoustic Startle and Pre-pulse Inhibition (PPI) % Pre-pulse inhibition - PPI1 homozygote Male abnormal sensory capabilities/reflexes/nociception 3.0197013778376913E-9
Ppp2r5e
Ppp2r5eem1(IMPC)Marc
Combined SHIRPA and Dysmorphology Locomotor activity homozygote Female hypoactivity 3.2074660705205815E-9
Ppp2r5e
Ppp2r5eem1(IMPC)Marc
Combined SHIRPA and Dysmorphology Locomotor activity homozygote Male hypoactivity 3.2074660705205815E-9
Cyp17a1
Cyp17a1tm1b(EUCOMM)Wtsi
Open Field Whole arena resting time homozygote Female hypoactivity 3.306200424546546E-9
Cyp17a1
Cyp17a1tm1b(EUCOMM)Wtsi
Open Field Whole arena resting time homozygote Male hypoactivity 3.306200424546546E-9
Cyp3a59
Cyp3a59em1(IMPC)Marc
Hematology Mean platelet volume heterozygote Female decreased mean platelet volume 3.362187639410763E-9
Cyp3a59
Cyp3a59em1(IMPC)Marc
Hematology Mean platelet volume heterozygote Male decreased mean platelet volume 3.362187639410763E-9
Fbxw2
Fbxw2tm1b(EUCOMM)Hmgu
Hematology Mean cell volume homozygote Female decreased mean corpuscular volume 3.4113416536030172E-9
Fbxw2
Fbxw2tm1b(EUCOMM)Hmgu
Hematology Mean cell volume homozygote Male decreased mean corpuscular volume 3.4113416536030172E-9
BC048403
BC048403tm1b(KOMP)Wtsi
Clinical Chemistry Phosphorus homozygote Female decreased circulating phosphate level 3.591631658750316E-9
BC048403
BC048403tm1b(KOMP)Wtsi
Clinical Chemistry Phosphorus homozygote Male decreased circulating phosphate level 3.591631658750316E-9
BC048403
BC048403tm1b(KOMP)Wtsi
Clinical Chemistry HDL-cholesterol homozygote Female decreased circulating HDL cholesterol level 3.632917078277842E-9
BC048403
BC048403tm1b(KOMP)Wtsi
Clinical Chemistry HDL-cholesterol homozygote Male decreased circulating HDL cholesterol level 3.632917078277842E-9
Hnrnpr
Hnrnprem1(IMPC)Marc
Hematology Mean cell hemoglobin concentration homozygote Female decreased mean corpuscular hemoglobin concentration 3.643342516568282E-9
Hnrnpr
Hnrnprem1(IMPC)Marc
Hematology Mean cell hemoglobin concentration homozygote Male decreased mean corpuscular hemoglobin concentration 3.643342516568282E-9
Esr2
Esr2em1(IMPC)Marc
Clinical Chemistry Albumin homozygote Female increased circulating serum albumin level 3.712842477909817E-9
Esr2
Esr2em1(IMPC)Marc
Clinical Chemistry Albumin homozygote Male increased circulating serum albumin level 3.712842477909817E-9
Dagla
Daglatm1a(EUCOMM)Wtsi
Body Composition (DEXA lean/fat) Lean mass homozygote Female decreased lean body mass 3.8512615319064025E-9
Dagla
Daglatm1a(EUCOMM)Wtsi
Body Composition (DEXA lean/fat) Lean mass homozygote Male decreased lean body mass 3.8512615319064025E-9
Lypd2
Lypd2em1(IMPC)Marc
Hematology Lymphocyte differential count homozygote Male increased lymphocyte cell number 3.86995768764109E-9
Dlgap2
Dlgap2em1(IMPC)Mhzh
Intraperitoneal glucose tolerance test (IPGTT) Fasted blood glucose concentration homozygote Female increased fasted circulating glucose level 3.880006982370787E-9
Dlgap2
Dlgap2em1(IMPC)Mhzh
Intraperitoneal glucose tolerance test (IPGTT) Fasted blood glucose concentration homozygote Male increased fasted circulating glucose level 3.880006982370787E-9
Hectd3
Hectd3tm1(NCOM)Cmhd
Body Composition (DEXA lean/fat) Body length homozygote Female decreased body length 4.56770532508699E-9
Hectd3
Hectd3tm1(NCOM)Cmhd
Body Composition (DEXA lean/fat) Body length homozygote Male decreased body length 4.56770532508699E-9
Tmem63a
Tmem63atm1(KOMP)Vlcg
Clinical Chemistry Alkaline phosphatase homozygote Female increased circulating alkaline phosphatase level 4.966230537917227E-9
Tmem63a
Tmem63atm1(KOMP)Vlcg
Clinical Chemistry Alkaline phosphatase homozygote Male increased circulating alkaline phosphatase level 4.966230537917227E-9
Ints6l
Ints6lem1(IMPC)Marc
Echo LVPWd hemizygote Male thin ventricular wall 5.26273069567651E-9
Phf5a
Phf5aem2(IMPC)Marc
Body Composition (DEXA lean/fat) Fat/Body weight heterozygote Female decreased total body fat amount 5.595946817038566E-9
Phf5a
Phf5aem2(IMPC)Marc
Body Composition (DEXA lean/fat) Fat/Body weight heterozygote Male decreased total body fat amount 5.595946817038566E-9
Lypd2
Lypd2em1(IMPC)Marc
Hematology Neutrophil differential count homozygote Male decreased neutrophil cell number 5.623031373858112E-9
Bbc3
Bbc3em1(IMPC)Marc
Hematology Mean cell hemoglobin concentration homozygote Female increased mean corpuscular hemoglobin concentration 7.261980794481815E-9
Bbc3
Bbc3em1(IMPC)Marc
Hematology Mean cell hemoglobin concentration homozygote Male increased mean corpuscular hemoglobin concentration 7.261980794481815E-9
Fbxo2
Fbxo2tm1b(EUCOMM)Wtsi
Acoustic Startle and Pre-pulse Inhibition (PPI) Response amplitude - S homozygote Female decreased startle reflex 7.822904102283701E-9
Fbxo2
Fbxo2tm1b(EUCOMM)Wtsi
Acoustic Startle and Pre-pulse Inhibition (PPI) Response amplitude - S homozygote Male decreased startle reflex 7.822904102283701E-9
Ints6l
Ints6lem1(IMPC)Marc
Echo LVIDs hemizygote Male dilated heart left ventricle 8.611096724564504E-9
Ppp2r3a
Ppp2r3atm1(KOMP)Mbp
Body Composition (DEXA lean/fat) Bone Area homozygote Female abnormal bone structure 9.016106083947761E-9
Ppp2r3a
Ppp2r3atm1(KOMP)Mbp
Body Composition (DEXA lean/fat) Bone Area homozygote Male abnormal bone structure 9.016106083947761E-9
Ctsm
Ctsmtm1(KOMP)Wtsi
Hematology Mean cell volume homozygote Female decreased mean corpuscular volume 9.240544329713885E-9
Ctsm
Ctsmtm1(KOMP)Wtsi
Hematology Mean cell volume homozygote Male decreased mean corpuscular volume 9.240544329713885E-9
Cpa1
Cpa1em1(IMPC)Marc
Hematology Lymphocyte cell count homozygote Male increased lymphocyte cell number 9.567468595150785E-9
Brcc3
Brcc3em1(IMPC)Marc
Hematology Mean corpuscular hemoglobin homozygote Female increased mean corpuscular hemoglobin 1.0537094752294252E-8
Brcc3
Brcc3em1(IMPC)Marc
Hematology Mean corpuscular hemoglobin homozygote Male increased mean corpuscular hemoglobin 1.0537094752294252E-8
Dagla
Daglatm1a(EUCOMM)Wtsi
Body Composition (DEXA lean/fat) Bone Mineral Density (excluding skull) homozygote Female decreased bone mineral density 1.1960892720708216E-8
Dagla
Daglatm1a(EUCOMM)Wtsi
Body Composition (DEXA lean/fat) Bone Mineral Density (excluding skull) homozygote Male decreased bone mineral density 1.1960892720708216E-8
Ccdc83
Ccdc83em1(IMPC)Marc
Hematology Lymphocyte cell count homozygote Female decreased lymphocyte cell number 1.2023922302262235E-8
Kdm2b
Kdm2bem1(IMPC)Marc
Clinical Chemistry Phosphorus heterozygote Female decreased circulating phosphate level 1.2851062436425309E-8
Kdm2b
Kdm2bem1(IMPC)Marc
Clinical Chemistry Phosphorus heterozygote Male decreased circulating phosphate level 1.2851062436425309E-8
Dlgap2
Dlgap2em1(IMPC)Mhzh
Body Composition (DEXA lean/fat) Fat mass homozygote Male decreased total body fat amount 1.3368198992225189E-8
Fbxo38
Fbxo38em2(IMPC)Marc
Body Composition (DEXA lean/fat) Bone Mineral Content (excluding skull) homozygote Female decreased bone mineral content 1.5758367055696E-8
Fbxo38
Fbxo38em2(IMPC)Marc
Body Composition (DEXA lean/fat) Bone Mineral Content (excluding skull) homozygote Male decreased bone mineral content 1.5758367055696E-8
Cox8a
Cox8aem1(IMPC)Marc
Clinical Chemistry Phosphorus homozygote Female decreased circulating phosphate level 1.7232713034331937E-8
Cox8a
Cox8aem1(IMPC)Marc
Clinical Chemistry Phosphorus homozygote Male decreased circulating phosphate level 1.7232713034331937E-8
Tmem63a
Tmem63atm1(KOMP)Vlcg
Clinical Chemistry Triglycerides homozygote Male increased circulating triglyceride level 1.7877074043326502E-8
Lypd2
Lypd2em1(IMPC)Marc
Hematology Neutrophil cell count homozygote Male decreased neutrophil cell number 1.7918742045708314E-8
Trim37
Trim37em1(IMPC)Marc
Body Composition (DEXA lean/fat) Fat/Body weight homozygote Female increased total body fat amount 1.798649229556304E-8
Pfkfb2
Pfkfb2tm1b(KOMP)Wtsi
Hematology Neutrophil differential count homozygote Female decreased neutrophil cell number 1.8461708606309912E-8
Pfkfb2
Pfkfb2tm1b(KOMP)Wtsi
Hematology Neutrophil differential count homozygote Male decreased neutrophil cell number 1.8461708606309912E-8
Gsdma3
Gsdma3tm1(KOMP)Vlcg
X-ray Kyphosis homozygote Male kyphosis 1.9241399584757346E-8
Gsdma3
Gsdma3tm1(KOMP)Vlcg
X-ray Scoliosis homozygote Male scoliosis 1.9241399584757346E-8
Gsdma3
Gsdma3tm1(KOMP)Vlcg
X-ray Lordosis homozygote Male lordosis 1.9241399584757346E-8
Lhcgr
Lhcgrtm1(KOMP)Vlcg
X-ray Fusion of processes homozygote Male fusion of vertebral arches 1.9241399584757346E-8
Mir320
Mir320tm1(mirKO)Wtsi
X-ray Fusion of processes heterozygote Male fusion of vertebral arches 1.9241399584757346E-8
Tmem63a
Tmem63atm1(KOMP)Vlcg
X-ray Fusion of processes homozygote Male fusion of vertebral arches 1.9241399584757346E-8
Mir141
Mir141tm1(mirKO)Wtsi
X-ray Fusion of processes heterozygote Male fusion of vertebral arches 1.9241399584757346E-8
Lhcgr
Lhcgrtm1(KOMP)Vlcg
X-ray Transitional vertebrae homozygote Male vertebral transformation 1.9241399584757346E-8
Mir320
Mir320tm1(mirKO)Wtsi
X-ray Transitional vertebrae heterozygote Male vertebral transformation 1.9241399584757346E-8
Tmem63a
Tmem63atm1(KOMP)Vlcg
X-ray Transitional vertebrae homozygote Male vertebral transformation 1.9241399584757346E-8
Mir141
Mir141tm1(mirKO)Wtsi
X-ray Transitional vertebrae heterozygote Male vertebral transformation 1.9241399584757346E-8
Lhcgr
Lhcgrtm1(KOMP)Vlcg
X-ray Polysyndactylism homozygote Male polysyndactyly 1.9241399584757346E-8
Mir320
Mir320tm1(mirKO)Wtsi
X-ray Polysyndactylism heterozygote Male polysyndactyly 1.9241399584757346E-8
Tmem63a
Tmem63atm1(KOMP)Vlcg
X-ray Polysyndactylism homozygote Male polysyndactyly 1.9241399584757346E-8
Mir141
Mir141tm1(mirKO)Wtsi
X-ray Polysyndactylism heterozygote Male polysyndactyly 1.9241399584757346E-8
Gsdma3
Gsdma3tm1(KOMP)Vlcg
X-ray Kyphosis homozygote Female kyphosis 2.033466017792307E-8
Gsdma3
Gsdma3tm1(KOMP)Vlcg
X-ray Scoliosis homozygote Female scoliosis 2.033466017792307E-8
Gsdma3
Gsdma3tm1(KOMP)Vlcg
X-ray Lordosis homozygote Female lordosis 2.033466017792307E-8
Lhcgr
Lhcgrtm1(KOMP)Vlcg
X-ray Fusion of processes homozygote Female fusion of vertebral arches 2.033466017792307E-8
Tmem63a
Tmem63atm1(KOMP)Vlcg
X-ray Fusion of processes homozygote Female fusion of vertebral arches 2.033466017792307E-8
Mir141
Mir141tm1(mirKO)Wtsi
X-ray Fusion of processes heterozygote Female fusion of vertebral arches 2.033466017792307E-8
Lhcgr
Lhcgrtm1(KOMP)Vlcg
X-ray Transitional vertebrae homozygote Female vertebral transformation 2.033466017792307E-8
Tmem63a
Tmem63atm1(KOMP)Vlcg
X-ray Transitional vertebrae homozygote Female vertebral transformation 2.033466017792307E-8
Mir141
Mir141tm1(mirKO)Wtsi
X-ray Transitional vertebrae heterozygote Female vertebral transformation 2.033466017792307E-8
Lhcgr
Lhcgrtm1(KOMP)Vlcg
X-ray Polysyndactylism homozygote Female polysyndactyly 2.033466017792307E-8
Tmem63a
Tmem63atm1(KOMP)Vlcg
X-ray Polysyndactylism homozygote Female polysyndactyly 2.033466017792307E-8
Mir141
Mir141tm1(mirKO)Wtsi
X-ray Polysyndactylism heterozygote Female polysyndactyly 2.033466017792307E-8
Cyp17a1
Cyp17a1tm1b(EUCOMM)Wtsi
Heart Weight Heart weight homozygote Female decreased heart weight 2.1650281567531238E-8
Cyp17a1
Cyp17a1tm1b(EUCOMM)Wtsi
Heart Weight Heart weight homozygote Male decreased heart weight 2.1650281567531238E-8
Phf5a
Phf5aem2(IMPC)Marc
Hematology Mean corpuscular hemoglobin heterozygote Female increased mean corpuscular hemoglobin 2.262750342651998E-8
Phf5a
Phf5aem2(IMPC)Marc
Hematology Mean corpuscular hemoglobin heterozygote Male increased mean corpuscular hemoglobin 2.262750342651998E-8
Suv39h2
Suv39h2em1(IMPC)Marc
Echo LVAWd homozygote Male decreased heart left ventricle size 2.4503888695903697E-8
Esr2
Esr2em1(IMPC)Marc
Hematology Monocyte cell count homozygote Female decreased neutrophil cell number 2.4534818621191334E-8
Esr2
Esr2em1(IMPC)Marc
Hematology Monocyte cell count homozygote Male decreased neutrophil cell number 2.4534818621191334E-8
Bbc3
Bbc3em1(IMPC)Marc
Hematology Mean corpuscular hemoglobin homozygote Female increased mean corpuscular hemoglobin 2.6529674457265173E-8
Bbc3
Bbc3em1(IMPC)Marc
Hematology Mean corpuscular hemoglobin homozygote Male increased mean corpuscular hemoglobin 2.6529674457265173E-8
Ces1f
Ces1ftm1b(KOMP)Wtsi
Combined SHIRPA and Dysmorphology Skin color - whole body homozygote Female abnormal skin coloration 2.890500994112699E-8
Brcc3
Brcc3em1(IMPC)Marc
Hematology Platelet count homozygote Female thrombocytosis 3.033181883438374E-8
Brcc3
Brcc3em1(IMPC)Marc
Hematology Platelet count homozygote Male thrombocytosis 3.033181883438374E-8
Cyp17a1
Cyp17a1tm1b(EUCOMM)Wtsi
Intraperitoneal glucose tolerance test (IPGTT) Area under glucose response curve homozygote Male improved glucose tolerance 3.0403889184071886E-8
Ppp2r5e
Ppp2r5eem1(IMPC)Marc
Hematology Hematocrit homozygote Female increased hematocrit 3.2274499517370714E-8
Ppp2r5e
Ppp2r5eem1(IMPC)Marc
Hematology Hematocrit homozygote Male increased hematocrit 3.2274499517370714E-8
Esr2
Esr2em1(IMPC)Marc
Body Composition (DEXA lean/fat) Fat/Body weight homozygote Male increased total body fat amount 3.3181581926555737E-8
Ppp2r2a
Ppp2r2atm1b(KOMP)Wtsi
Hematology White blood cell count heterozygote Female increased leukocyte cell number 3.526258396391313E-8
Ppp2r2a
Ppp2r2atm1b(KOMP)Wtsi
Hematology White blood cell count heterozygote Male decreased leukocyte cell number 3.526258396391313E-8
Ccdc83
Ccdc83em1(IMPC)Marc
Hematology Monocyte cell count homozygote Female decreased neutrophil cell number 3.534362491564025E-8
Ccdc83
Ccdc83em1(IMPC)Marc
Hematology Monocyte cell count homozygote Male decreased neutrophil cell number 3.534362491564025E-8
Fshr
Fshrtm1(KOMP)Vlcg
Hematology Lymphocyte cell count homozygote Female increased lymphocyte cell number 3.564690587154473E-8
Ints6l
Ints6lem1(IMPC)Marc
Echo LVPWs hemizygote Male decreased heart left ventricle size 4.0792841105030675E-8
Ehmt1
Ehmt1tm1b(EUCOMM)Hmgu
Open Field Whole arena average speed heterozygote Female hypoactivity 4.222780347618027E-8
Ehmt1
Ehmt1tm1b(EUCOMM)Hmgu
Open Field Whole arena average speed heterozygote Male hypoactivity 4.222780347618027E-8
Cyld
Cyldem2(IMPC)Marc
Open Field Number of center entries homozygote Female abnormal behavior 5.723765283960347E-8
Cyld
Cyldem2(IMPC)Marc
Open Field Number of center entries homozygote Male abnormal behavior 5.723765283960347E-8
Fbxl2
Fbxl2em2(IMPC)Marc
Hematology Mean corpuscular hemoglobin homozygote Female increased mean corpuscular hemoglobin 6.071531544193931E-8
Ash1l
Ash1ltm2b(EUCOMM)Hmgu
Heart Weight Heart weight heterozygote Male increased heart weight 6.106312611109388E-8
Ppp2r2a
Ppp2r2atm1b(KOMP)Wtsi
Hematology Lymphocyte cell count heterozygote Male decreased lymphocyte cell number 6.25620515393166E-8
Ppp2r2a
Ppp2r2atm1b(KOMP)Wtsi
Hematology Lymphocyte cell count heterozygote Female increased lymphocyte cell number 6.25620515393166E-8
Slco6c1
Slco6c1em1(IMPC)Marc
Clinical Chemistry Phosphorus homozygote Female decreased circulating phosphate level 7.010355318470829E-8
Slco6c1
Slco6c1em1(IMPC)Marc
Clinical Chemistry Phosphorus homozygote Male decreased circulating phosphate level 7.010355318470829E-8
Fbxo38
Fbxo38em2(IMPC)Marc
Grip Strength Forelimb and hindlimb grip strength measurement mean homozygote Female decreased grip strength 7.860597150965987E-8
Fbxo38
Fbxo38em2(IMPC)Marc
Grip Strength Forelimb and hindlimb grip strength measurement mean homozygote Male decreased grip strength 7.860597150965987E-8
Fbxo10
Fbxo10tm1b(KOMP)Wtsi
Hematology Basophil differential count homozygote Female decreased basophil cell number 8.95743070827848E-8
Fbxo10
Fbxo10tm1b(KOMP)Wtsi
Hematology Basophil differential count homozygote Male decreased basophil cell number 8.95743070827848E-8
Atg4a
Atg4aem2(IMPC)Marc
Body Composition (DEXA lean/fat) Fat mass homozygote Male increased total body fat amount 9.987604698835639E-8
Fbxw13
Fbxw13em2(IMPC)Marc
Hematology Mean corpuscular hemoglobin homozygote Female increased mean corpuscular hemoglobin 1.086312622078367E-7
Fbxw13
Fbxw13em2(IMPC)Marc
Hematology Mean corpuscular hemoglobin homozygote Male increased mean corpuscular hemoglobin 1.086312622078367E-7
Hnrnpr
Hnrnprem1(IMPC)Marc
Hematology White blood cell count homozygote Female increased leukocyte cell number 1.1443367498031876E-7
Hnrnpr
Hnrnprem1(IMPC)Marc
Hematology White blood cell count homozygote Male increased leukocyte cell number 1.1443367498031876E-7
Hectd3
Hectd3tm1(NCOM)Cmhd
Open Field Center distance travelled homozygote Female abnormal behavior 1.1685801837302279E-7
Hectd3
Hectd3tm1(NCOM)Cmhd
Open Field Center distance travelled homozygote Male abnormal behavior 1.1685801837302279E-7
Ints6l
Ints6lem1(IMPC)Marc
Echo LVIDd hemizygote Male dilated heart left ventricle 1.205728352715596E-7
Fbxo43
Fbxo43em1(IMPC)Marc
Hematology Red blood cell count homozygote Female increased erythrocyte cell number 1.3141404053840233E-7
Fbxo43
Fbxo43em1(IMPC)Marc
Hematology Red blood cell count homozygote Male increased erythrocyte cell number 1.3141404053840233E-7
Phf11a
Phf11atm1b(NCOM)Mfgc
Clinical Chemistry Triglycerides heterozygote Male increased circulating triglyceride level 1.3344116212010704E-7
Usp11
Usp11em1(IMPC)Marc
Hematology Basophil differential count hemizygote Male decreased basophil cell number 1.345895412896425E-7
Fbxo43
Fbxo43em1(IMPC)Marc
Hematology Hematocrit homozygote Female increased hematocrit 1.390429247294378E-7
Fbxo43
Fbxo43em1(IMPC)Marc
Hematology Hematocrit homozygote Male increased hematocrit 1.390429247294378E-7
Atg4a
Atg4aem2(IMPC)Marc
Body Composition (DEXA lean/fat) BMC/Body weight homozygote Male decreased bone mineral content 1.526088482250998E-7
Phf3
Phf3em2(IMPC)Marc
Hematology Red blood cell count homozygote Male increased erythrocyte cell number 1.5968855393566628E-7
Dusp7
Dusp7tm1(KOMP)Wtsi
Clinical Chemistry HDL-cholesterol homozygote Female decreased circulating HDL cholesterol level 1.6321354223691742E-7
Dusp7
Dusp7tm1(KOMP)Wtsi
Clinical Chemistry HDL-cholesterol homozygote Male decreased circulating HDL cholesterol level 1.6321354223691742E-7
Aars2
Aars2tm1(KOMP)Wtsi
Hematology Red blood cell distribution width heterozygote Female decreased red blood cell distribution width 1.655538994782546E-7
Aars2
Aars2tm1(KOMP)Wtsi
Hematology Red blood cell distribution width heterozygote Male decreased red blood cell distribution width 1.655538994782546E-7
Cpa1
Cpa1em1(IMPC)Marc
Hematology Neutrophil differential count homozygote Female decreased neutrophil cell number 1.8950075286738866E-7
Cpa1
Cpa1em1(IMPC)Marc
Hematology Neutrophil differential count homozygote Male decreased neutrophil cell number 1.8950075286738866E-7
Bbof1
Bbof1em1(IMPC)Marc
Hematology Neutrophil differential count homozygote Male decreased neutrophil cell number 1.9264315653799713E-7
Dlgap2
Dlgap2em1(IMPC)Mhzh
Body Composition (DEXA lean/fat) Fat/Body weight homozygote Female decreased total body fat amount 2.033886659091877E-7
Dlgap2
Dlgap2em1(IMPC)Mhzh
Body Composition (DEXA lean/fat) Fat/Body weight homozygote Male decreased total body fat amount 2.033886659091877E-7
Phf5a
Phf5aem2(IMPC)Marc
Body Composition (DEXA lean/fat) Lean/Body weight heterozygote Female increased lean body mass 2.0878525219814037E-7
Phf5a
Phf5aem2(IMPC)Marc
Body Composition (DEXA lean/fat) Lean/Body weight heterozygote Male increased lean body mass 2.0878525219814037E-7
Esr2
Esr2em1(IMPC)Marc
Body Composition (DEXA lean/fat) Lean/Body weight homozygote Male decreased lean body mass 2.1252095905310853E-7
Atg4b
Atg4bem1(IMPC)Marc
Clinical Chemistry Alkaline phosphatase homozygote Female increased circulating alkaline phosphatase level 2.1623343116061733E-7
Ufm1
Ufm1em1(IMPC)Marc
Clinical Chemistry Triglycerides heterozygote Male increased circulating triglyceride level 2.1773205105546367E-7
Usp31
Usp31em1(IMPC)Marc
Hematology Mean cell volume homozygote Female decreased mean corpuscular volume 2.1849700715392828E-7
Usp31
Usp31em1(IMPC)Marc
Hematology Mean cell volume homozygote Male decreased mean corpuscular volume 2.1849700715392828E-7
Otud6a
Otud6atm1(KOMP)Vlcg
Clinical Chemistry HDL-cholesterol homozygote Female increased circulating HDL cholesterol level 2.2130070931325463E-7
Otud6a
Otud6atm1(KOMP)Vlcg
Clinical Chemistry HDL-cholesterol homozygote Male increased circulating HDL cholesterol level 2.2130070931325463E-7
Hectd3
Hectd3tm1(NCOM)Cmhd
Grip Strength Forelimb grip strength measurement mean homozygote Female decreased grip strength 2.2959646628351038E-7
Hectd3
Hectd3tm1(NCOM)Cmhd
Grip Strength Forelimb grip strength measurement mean homozygote Male decreased grip strength 2.2959646628351038E-7
Bend3
Bend3tm1b(KOMP)Mbp
Combined SHIRPA and Dysmorphology Coat - color - head heterozygote Male abnormal coat/hair pigmentation 2.3398570192512125E-7
Dusp7
Dusp7tm1(KOMP)Wtsi
Combined SHIRPA and Dysmorphology Coat - color pattern - head homozygote Male abnormal coat/hair pigmentation 2.49256004281051E-7
Cdc42ep5
Cdc42ep5tm1(KOMP)Wtsi
Combined SHIRPA and Dysmorphology Coat - color - head homozygote Female abnormal coat/hair pigmentation 2.5702220796119946E-7
Ppp2r3a
Ppp2r3atm1(KOMP)Mbp
Body Composition (DEXA lean/fat) Bone Mineral Content (excluding skull) homozygote Female decreased bone mineral content 2.639265233028709E-7
Ppp2r3a
Ppp2r3atm1(KOMP)Mbp
Body Composition (DEXA lean/fat) Bone Mineral Content (excluding skull) homozygote Male decreased bone mineral content 2.639265233028709E-7
Fbxw2
Fbxw2tm1b(EUCOMM)Hmgu
Hematology Red blood cell count homozygote Male increased erythrocyte cell number 2.6448432777215203E-7
Bend3
Bend3tm1b(KOMP)Mbp
Combined SHIRPA and Dysmorphology Coat - color - abdomen heterozygote Male abnormal coat/hair pigmentation 3.063522910906613E-7
Hnrnpd
Hnrnpdtm1b(KOMP)Wtsi
Open Field Periphery permanence time heterozygote Female abnormal behavior 3.133073676053755E-7
Hnrnpd
Hnrnpdtm1b(KOMP)Wtsi
Open Field Periphery permanence time heterozygote Male abnormal behavior 3.133073676053755E-7
Hnrnpd
Hnrnpdtm1b(KOMP)Wtsi
Open Field Percentage center time heterozygote Female abnormal behavior 3.2292652463183913E-7
Hnrnpd
Hnrnpdtm1b(KOMP)Wtsi
Open Field Percentage center time heterozygote Male abnormal behavior 3.2292652463183913E-7
Hnrnpd
Hnrnpdtm1b(KOMP)Wtsi
Open Field Center permanence time heterozygote Female abnormal behavior 3.2356714996240044E-7
Hnrnpd
Hnrnpdtm1b(KOMP)Wtsi
Open Field Center permanence time heterozygote Male abnormal behavior 3.2356714996240044E-7
Pfkfb2
Pfkfb2tm1b(KOMP)Wtsi
Hematology Lymphocyte differential count homozygote Female increased lymphocyte cell number 3.2519307069378556E-7
Pfkfb2
Pfkfb2tm1b(KOMP)Wtsi
Hematology Lymphocyte differential count homozygote Male increased lymphocyte cell number 3.2519307069378556E-7
Usp31
Usp31em1(IMPC)Marc
Hematology Eosinophil differential count homozygote Female increased eosinophil cell number 3.3145687439173344E-7
Cdc42ep5
Cdc42ep5tm1(KOMP)Wtsi
Combined SHIRPA and Dysmorphology Coat - color - abdomen homozygote Female abnormal coat/hair pigmentation 3.3182848824253597E-7
Prdm2
Prdm2em1(IMPC)Marc
Hematology Mean cell volume homozygote Female decreased mean corpuscular volume 3.556601484433486E-7
Prdm2
Prdm2em1(IMPC)Marc
Hematology Mean cell volume homozygote Male decreased mean corpuscular volume 3.556601484433486E-7
Mir320
Mir320tm1(mirKO)Wtsi
X-ray Fusion of processes heterozygote Female fusion of vertebral arches 3.741577074833913E-7
Mir320
Mir320tm1(mirKO)Wtsi
X-ray Transitional vertebrae heterozygote Female vertebral transformation 3.741577074833913E-7
Mir320
Mir320tm1(mirKO)Wtsi
X-ray Polysyndactylism heterozygote Female polysyndactyly 3.741577074833913E-7
AW112010
AW112010em1(IMPC)Marc
Hematology Mean corpuscular hemoglobin homozygote Male decreased mean corpuscular hemoglobin 3.797762531121407E-7
Ints6l
Ints6lem1(IMPC)Marc
Echo LVAWd homozygote Female decreased heart left ventricle size 3.8317318740155315E-7
Fbxw13
Fbxw13em2(IMPC)Marc
Hematology Red blood cell distribution width homozygote Female decreased red blood cell distribution width 3.834888389064872E-7
Fbxw13
Fbxw13em2(IMPC)Marc
Hematology Red blood cell distribution width homozygote Male decreased red blood cell distribution width 3.834888389064872E-7
Dagla
Daglatm1a(EUCOMM)Wtsi
Body Composition (DEXA lean/fat) Body length homozygote Female decreased body length 3.944005868561362E-7
Dagla
Daglatm1a(EUCOMM)Wtsi
Body Composition (DEXA lean/fat) Body length homozygote Male decreased body length 3.944005868561362E-7
Phf21b
Phf21bem1(IMPC)Marc
Echo LVAWd homozygote Female decreased heart left ventricle size 4.040073520172882E-7
Phf21b
Phf21bem1(IMPC)Marc
Echo LVAWd homozygote Male decreased heart left ventricle size 4.040073520172882E-7
Phf5a
Phf5aem2(IMPC)Marc
Hematology Mean cell volume heterozygote Female increased mean corpuscular volume 4.1152355834128684E-7
Phf5a
Phf5aem2(IMPC)Marc
Hematology Mean cell volume heterozygote Male increased mean corpuscular volume 4.1152355834128684E-7
Fbxw13
Fbxw13em2(IMPC)Marc
Hematology Neutrophil cell count homozygote Female decreased neutrophil cell number 4.4982519398217846E-7
Fbxw13
Fbxw13em2(IMPC)Marc
Hematology Neutrophil cell count homozygote Male decreased neutrophil cell number 4.4982519398217846E-7
Ehmt1
Ehmt1tm1b(EUCOMM)Hmgu
Open Field Periphery average speed heterozygote Female abnormal behavior 4.796012831320695E-7
Ehmt1
Ehmt1tm1b(EUCOMM)Hmgu
Open Field Periphery average speed heterozygote Male abnormal behavior 4.796012831320695E-7
Ppp2r5e
Ppp2r5eem1(IMPC)Marc
Body Composition (DEXA lean/fat) Bone Mineral Content (excluding skull) homozygote Female decreased bone mineral content 4.891061848866229E-7
Ppp2r5e
Ppp2r5eem1(IMPC)Marc
Body Composition (DEXA lean/fat) Bone Mineral Content (excluding skull) homozygote Male decreased bone mineral content 4.891061848866229E-7
Adarb1
Adarb1em1(IMPC)Marc
Hematology Hematocrit heterozygote Female increased hematocrit 4.97840233038005E-7
Adarb1
Adarb1em1(IMPC)Marc
Hematology Hematocrit heterozygote Male increased hematocrit 4.97840233038005E-7
Hilpda
Hilpdaem1(IMPC)Mhzh
Auditory Brain Stem Response 12kHz-evoked ABR Threshold homozygote decreased threshold for auditory brainstem response 4.999999987376214E-7
Ppp2r5e
Ppp2r5eem1(IMPC)Marc
Hematology Mean cell hemoglobin concentration homozygote Female decreased mean corpuscular hemoglobin concentration 5.075632429907273E-7
Ppp2r5e
Ppp2r5eem1(IMPC)Marc
Hematology Mean cell hemoglobin concentration homozygote Male decreased mean corpuscular hemoglobin concentration 5.075632429907273E-7
Etaa1
Etaa1em1(IMPC)Marc
Hematology Mean platelet volume homozygote Female increased mean platelet volume 5.547772161662579E-7
Etaa1
Etaa1em1(IMPC)Marc
Hematology Mean platelet volume homozygote Male increased mean platelet volume 5.547772161662579E-7
Ccdc129
Ccdc129em1(IMPC)Marc
Hematology Lymphocyte differential count homozygote Male decreased lymphocyte cell number 6.030664394529595E-7
Usp47
Usp47tm1b(EUCOMM)Wtsi
Hematology Lymphocyte differential count homozygote Male increased lymphocyte cell number 6.161465080367634E-7
Fbxl8
Fbxl8em2(IMPC)Marc
Hematology Monocyte differential count homozygote Female increased monocyte cell number 6.564048362633912E-7
Fbxl8
Fbxl8em2(IMPC)Marc
Hematology Monocyte differential count homozygote Male increased monocyte cell number 6.564048362633912E-7
BC048403
BC048403tm1b(KOMP)Wtsi
Clinical Chemistry Total cholesterol homozygote Female decreased circulating cholesterol level 6.624917432418442E-7
Senp7
Senp7tm1b(EUCOMM)Hmgu
Combined SHIRPA and Dysmorphology Coat - color - head homozygote Female abnormal coat/hair pigmentation 6.680077149212593E-7
Phf8
Phf8em1(IMPC)Marc
Hematology Basophil differential count hemizygote Male decreased basophil cell number 7.231438985400018E-7
Alg1
Alg1tm1b(KOMP)Wtsi
Combined SHIRPA and Dysmorphology Coat - color pattern - back heterozygote Male abnormal coat/hair pigmentation 7.425654189319175E-7
Dusp7
Dusp7tm1(KOMP)Wtsi
Combined SHIRPA and Dysmorphology Coat - color pattern - back homozygote Male abnormal coat/hair pigmentation 7.425654189319175E-7
Prpf31
Prpf31tm1a(EUCOMM)Wtsi
Intraperitoneal glucose tolerance test (IPGTT) Fasted blood glucose concentration heterozygote Female increased fasted circulating glucose level 7.697832415942685E-7
Prpf31
Prpf31tm1a(EUCOMM)Wtsi
Intraperitoneal glucose tolerance test (IPGTT) Fasted blood glucose concentration heterozygote Male increased fasted circulating glucose level 7.697832415942685E-7
Fbxw8
Fbxw8tm1b(EUCOMM)Hmgu
Clinical Chemistry Creatinine heterozygote Male increased circulating creatinine level 7.883127750574204E-7
Gsdma3
Gsdma3tm1(KOMP)Vlcg
Clinical Chemistry Calcium homozygote Female decreased circulating calcium level 7.890999995652237E-7
Gsdma3
Gsdma3tm1(KOMP)Vlcg
Clinical Chemistry Calcium homozygote Male decreased circulating calcium level 7.890999995652237E-7
Phf5a
Phf5aem2(IMPC)Marc
Hematology Red blood cell count heterozygote Female decreased erythrocyte cell number 7.911968396001612E-7
Phf5a
Phf5aem2(IMPC)Marc
Hematology Red blood cell count heterozygote Male decreased erythrocyte cell number 7.911968396001612E-7
Wfdc11
Wfdc11em1(IMPC)Marc
Hematology Red blood cell distribution width homozygote Female decreased red blood cell distribution width 7.987962362676626E-7
Wfdc11
Wfdc11em1(IMPC)Marc
Hematology Red blood cell distribution width homozygote Male decreased red blood cell distribution width 7.987962362676626E-7
Etaa1
Etaa1em1(IMPC)Marc
Body Composition (DEXA lean/fat) Bone Area homozygote Female abnormal bone structure 8.244319360528607E-7
Etaa1
Etaa1em1(IMPC)Marc
Body Composition (DEXA lean/fat) Bone Area homozygote Male abnormal bone structure 8.244319360528607E-7
Senp7
Senp7tm1b(EUCOMM)Hmgu
Combined SHIRPA and Dysmorphology Coat - color - abdomen homozygote Female abnormal coat/hair pigmentation 8.614126159045554E-7
Ints6l
Ints6lem1(IMPC)Marc
Echo Ejection Fraction hemizygote Male decreased cardiac muscle contractility 8.623898111181916E-7
Ints6l
Ints6lem1(IMPC)Marc
Echo LVAWd hemizygote Male decreased heart left ventricle size 9.028485692397226E-7
Bbof1
Bbof1em1(IMPC)Marc
Hematology Lymphocyte differential count homozygote Male increased lymphocyte cell number 9.039709425451292E-7
Fbxl19
Fbxl19tm1b(EUCOMM)Wtsi
Clinical Chemistry Glucose heterozygote Female decreased circulating glucose level 9.575318244969822E-7
Fbxl19
Fbxl19tm1b(EUCOMM)Wtsi
Clinical Chemistry Glucose heterozygote Male decreased circulating glucose level 9.575318244969822E-7
Hnrnph1
Hnrnph1tm1b(KOMP)Wtsi
Hematology Neutrophil differential count heterozygote Female decreased neutrophil cell number 9.685109034762718E-7
Hnrnph1
Hnrnph1tm1b(KOMP)Wtsi
Hematology Neutrophil differential count heterozygote Male decreased neutrophil cell number 9.685109034762718E-7
Phf21b
Phf21bem1(IMPC)Marc
Echo LVAWs homozygote Female thin ventricular wall 9.880594689093414E-7
Phf21b
Phf21bem1(IMPC)Marc
Echo LVAWs homozygote Male thin ventricular wall 9.880594689093414E-7
Usp36
Usp36tm1b(EUCOMM)Hmgu
Clinical Chemistry Glucose heterozygote Female increased circulating glucose level 1.0119372291228501E-6
Usp36
Usp36tm1b(EUCOMM)Hmgu
Clinical Chemistry Glucose heterozygote Male increased circulating glucose level 1.0119372291228501E-6